HOME >> BIOLOGY >> NEWS
New roles for protein modifications in cell migration

evels. MIG-17 molecules designed with deficient glycosylation sites also failed to localize at the gonad and showed no ability to direct its migration. Genetic analyses revealed that MIG-23 is expressed in muscle cells, which reconciles well with MIG-17fs muscle cell origins. Taken together, these results indicate that MIG-17 molecules are secreted from muscle cells after glycosylation by MIG-23, a modification which enables their recruitment to the migrating gonad.

Although Golgi NDPases such as MIG-23 can conceivably modify a number of other secreted proteins, the Nishiwaki study indicates that the effects of the NDPase dysfunction are especially prominent in the abnormal glycosylation and function of an ADAM family protease, suggesting that glycosylation may play a more important role in the function of proteins in this family than it does in that of other secreted proteins. ADAM family proteases are known to be involved in a number of human diseases, and the question of whether glycosylation defects play a role in their pathogenesis merits further investigation. Research such as this provides insights into basic biological mechanisms that may one day make it possible to treat a range of health conditions by restoring normal ADAM protease glycosylation in cases in which it is aberrant.


'"/>

Contact: Doug Sipp
sipp@cdb.riken.jp
RIKEN Center for Developmental Biology
25-Dec-2003


Page: 1 2 3

Related biology news :

1. UT Southwestern scientists prove certain proteins play unexpected roles in genetic transcription
2. New molecular link key to cellular proteins involved in cancer progression, other diseases
3. Researchers identify protein promoting vascular tumor growth
4. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
5. Experimental drug shown to block mutant protein causing blood disease
6. Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction
7. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
8. New dye directly reveals activated proteins in living cells
9. Disruption of protein-folding causes neurodegeneration, mental retardation
10. A new protein is discovered to play a key role in cancer progression
11. Optimizing proteins death domain halts leukemia in laboratory study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New roles for protein modifications cell migration

(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
(Date:5/21/2013)... CAMBRIDGE, MA -- Over the past few decades, scientists ... including angioplasty balloons and metallic stents. While generally effective, ... of side effects. , A new study from MIT ... combines the benefits of angioplasty balloons and drug-releasing stents, ... a balloon is inflated in the artery for only ...
(Date:5/21/2013)... path of insulin action in cells in precise detail ... understanding what goes wrong in diabetes. , The ... James from Sydney,s Garvan Institute of Medical Research, is ... prestigious journal Cell Metabolism . , First discovered ... role in the body because it helps us lower ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
(Date:5/21/2013)... York , May 21, 2013 ... Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and ... IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and ... billion in 2011 and is expected to grow at ... reach an estimated value of USD 4.7 billion in ...
(Date:5/21/2013)... -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics ... announced today that Jeffrey Riley , CEO, ... MicroCap Conference on Thursday, May 30, 2013 in ... Mr. Riley is scheduled to present at 10:00 a.m. (Eastern ... can be accessed by logging onto the web at ...
(Date:5/21/2013)... 21, 2013 Inflamax scientists worked ... ITN to design the study, which will provide ... clinical models used in the study of allergy ... Allergen Challenge (NAC) models. Although both the models ... to date no direct comparison between the allergic ...
(Date:5/21/2013)... 21, 2013 The Formulate Fusion Fabric ... for sales and marketing teams looking for a fully-functional package ... kit as “everything you’ll need to put together a stunning ... comes with a number of displays and accessories that can ... feet by 20 feet in size. These components vary from ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2
Cached News: